Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Mesothelioma × Surveys and Questionnaires × Clear all

Sponsor

Conditions

Breast Neoplasms 10 cyclopia sequence 7 Neoplasms 6 Multiple Myeloma 5 Fatigue 5 Neoplasms, Plasma Cell 4 Neoplasm Metastasis 4 Lung Neoplasms 4 Anxiety Disorders 4 Uterine Cervical Neoplasms 3 Tobacco Use Cessation 3 Primary Myelofibrosis 3 Leukemia 3 Dyspnea 3 Depression 3 Carcinoma, Non-Small-Cell Lung 3 Vomiting 2 Smoking Cessation 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Polycythemia Vera 2 Parasomnias 2 Pancreatic Neoplasms 2 Pain 2 Osteosarcoma 2 Kidney Neoplasms 2 Hodgkin Disease 2 Hematologic Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 Agnosia 2

Interventions

Pemetrexed 11 Cisplatin 10 pembrolizumab 7 Carboplatin 6 Ipilimumab 5 Nivolumab 4 durvalumab 3 LMB-100 3 Gemcitabine 3 tremelimumab 2 tazemetostat 2 anetumab ravtansine 2 Vinorelbine 2 Plicamycin 2 Dexamethasone 2 Cyclophosphamide 2 Bevacizumab 2 vandetanib 1 tocilizumab 1 ribociclib 1 rebastinib 1 pevonedistat 1 olaparib 1 niraparib 1 nintedanib 1 fludarabine phosphate 1 fludarabine 1 epacadostat 1 enzalutamide 1 defactinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡